港股升幅擴至逾450點 騰訊(00700.HK)績前升逾3%創四年高 騰訊音樂(01698.HK)首度晉身「紅底股」
美上月通脹符預期,隔晚(12日)美股標普500指數及納指破頂。貝萊德預計聯儲局將在9月開始減息,將聯邦基金利率下調50個點子可能是合理的決定。內地A股兩市今早(13日)造好,滬綜指升見3,685創2021年12月以來逾三年半高。港股今早高開206點或0.8%後升幅擴大,曾升459點,高見25,429,最新報25,425,升455點或1.8%,成交1,218.87億元。
權重科技股推升大市。市場聚焦騰訊(00700.HK)今日收市後公布中期業績,績前股價繼續向好,早段升見579.5元再創約四年高;最新報578.5元,升3.4%,成交74.08億元。另小米-W(01810.HK)升2.1%、百度-SW(09888.HK)、京東-SW(09618.HK)、美團-SW(03690.HK)升3%至3.2%、阿里-W(09988.HK)漲4.5%。上日急跌的快手-W(01024.HK)早段反彈3.3%,報74元,成交19.52億元。瑞銀認為,市場誤解快手與美團合作,快手並不會直接參與外送業務,重申快手「買入」評級。
萬洲(00288.HK)現報8.32元,升5.72%,屬藍籌股表現最好。公司上半年以生物公允價值調整前計純利7.25億美元,按年升4.5%;中期息按年倍升至20港仙。行政總裁郭麗軍在業績電話會議上表示,集團在現時中美貿易戰下仍有盈利空間,集團美國市場的採購及銷售主要在美國,認為關稅對集團營運基本沒有太大影響。另石藥(01093.HK)、中升(00881.HK)各升逾5%,包攬藍籌股升幅首三位。
醫藥股造好,藥明康德(02359.HK)及藥明生物(02269.HK)各升4.5%及3%、翰森(03692.HK)升4.4%、中生製藥(01177.HK)升2.7%。
權重金融股亦支撐大市,友邦(01299.HK)及港交所(00388.HK)各升約2%、匯控(00005.HK)及中國平安(02318.HK)亦升1.2%至1.4%。
焦點股方面,騰訊音樂-SW(01698.HK)承過去四連升勢,早段曾升17.8%高見104元創上市高,現報101.7元,升15.18%,成交2.2億元;其次季Non-IFRS純利錄25.74億元人民幣,按年增長37.4%。
新消費股表現分化,蜜雪(02097.HK)升2.1%、老鋪黃金(06181.HK)微跌不足0.1%、泡泡瑪特(09992.HK)微升0.3%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.